| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9011897 | ZUREX PHARMA | Catheter lock solution comprising citrate and a paraben |
Feb, 2025
(9 months from now) | |
| US8226971 | ZUREX PHARMA | Catheter lock solution comprising citrate and a paraben |
May, 2025
(1 year, 12 days from now) | |
| US8703828 | ZUREX PHARMA | Antimicrobial compositions and methods of use |
May, 2028
(4 years from now) | |
| US9629368 | ZUREX PHARMA | Antimicrobial compositions and methods of use |
May, 2028
(4 years from now) | |
| US8389583 | ZUREX PHARMA | Antimicrobial compositions and methods of use |
Aug, 2029
(5 years from now) | |
| US10688291 | ZUREX PHARMA | Medical skin applicator apparatus |
Dec, 2034
(10 years from now) | |
| US9844654 | ZUREX PHARMA | Medical skin applicator apparatus |
Apr, 2036
(12 years from now) | |
Zuragard is owned by Zurex Pharma.
Zuragard contains Isopropyl Alcohol.
Zuragard has a total of 7 drug patents out of which 0 drug patents have expired.
Zuragard was authorised for market use on 26 April, 2019.
Zuragard is available in solution;topical dosage forms.
Zuragard can be used as use as an antiseptic for the preparation of a patient's skin prior to surgery.
The generics of Zuragard are possible to be released after 24 April, 2036.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-268) | Jun 24, 2024 |
| New Product(NP) | Apr 26, 2022 |
Drugs and Companies using ISOPROPYL ALCOHOL ingredient
Market Authorisation Date: 26 April, 2019
Treatment: Use as an antiseptic for the preparation of a patient's skin prior to surgery
Dosage: SOLUTION;TOPICAL
ZURAGARD family patents
